Handelsbanken Fonder’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Sell |
25,415
-100
| -0.4% | -$1.71K | ﹤0.01% | 1301 |
|
|
2025
Q1 | $1.63M | Hold |
25,515
| – | – | 0.01% | 730 |
|
|
2024
Q4 | $3.1M | Buy |
25,515
+1,700
| +7% | +$207K | 0.01% | 544 |
|
|
2024
Q3 | $2.97M | Buy |
23,815
+2,600
| +12% | +$325K | 0.01% | 543 |
|
|
2024
Q2 | $3.35M | Buy |
21,215
+2,900
| +16% | +$458K | 0.01% | 468 |
|
|
2024
Q1 | $2.37M | Buy |
18,315
+1,500
| +9% | +$194K | 0.01% | 560 |
|
|
2023
Q4 | $1.62M | Buy |
16,815
+900
| +6% | +$86.8K | 0.01% | 610 |
|
|
2023
Q3 | $1.93M | Buy |
15,915
+2,013
| +14% | +$244K | 0.01% | 553 |
|
|
2023
Q2 | $1.59M | Buy |
13,902
+900
| +7% | +$103K | 0.01% | 593 |
|
|
2023
Q1 | $1.79M | Buy |
13,002
+1,400
| +12% | +$193K | 0.01% | 554 |
|
|
2022
Q4 | $1.5M | Hold |
11,602
| – | – | 0.01% | 562 |
|
|
2022
Q3 | $1.28M | Hold |
11,602
| – | – | 0.01% | 590 |
|
|
2022
Q2 | $870K | Sell |
11,602
-1,500
| -11% | -$112K | 0.01% | 740 |
|
|
2022
Q1 | $1.02M | Hold |
13,102
| – | – | 0.01% | 789 |
|
|
2021
Q4 | $1.18M | Hold |
13,102
| – | – | 0.01% | 812 |
|
|
2021
Q3 | $1.21M | Hold |
13,102
| – | – | 0.01% | 804 |
|
|
2021
Q2 | $1.02M | Sell |
13,102
-1,600
| -11% | -$124K | 0.01% | 911 |
|
|
2021
Q1 | $1.1M | Sell |
14,702
-39,500
| -73% | -$2.94M | 0.01% | 797 |
|
|
2020
Q4 | $9.24M | Hold |
54,202
| – | – | 0.06% | 292 |
|
|
2020
Q3 | $7.61M | Hold |
54,202
| – | – | 0.06% | 283 |
|
|
2020
Q2 | $8.69M | Buy |
54,202
+22,702
| +72% | +$3.64M | 0.07% | 240 |
|
|
2020
Q1 | $3.08M | Buy |
31,500
+10,000
| +47% | +$978K | 0.07% | 151 |
|
|
2019
Q4 | $2.77M | Hold |
21,500
| – | – | 0.05% | 171 |
|
|
2019
Q3 | $1.62M | Hold |
21,500
| – | – | 0.03% | 170 |
|
|
2019
Q2 | $3.27M | Sell |
21,500
-5,000
| -19% | -$760K | 0.06% | 166 |
|
|
2019
Q1 | $3.16M | Hold |
26,500
| – | – | 0.06% | 161 |
|
|
2018
Q4 | $2.89M | Sell |
26,500
-6,000
| -18% | -$655K | 0.06% | 152 |
|
|
2018
Q3 | $5.25M | Buy |
32,500
+3,000
| +10% | +$485K | 0.1% | 144 |
|
|
2018
Q2 | $3.9M | Sell |
29,500
-4,000
| -12% | -$529K | 0.08% | 154 |
|
|
2018
Q1 | $2.48M | Buy |
33,500
+12,000
| +56% | +$889K | 0.05% | 168 |
|
|
2017
Q4 | $1.2M | Buy |
+21,500
| New | +$1.2M | 0.03% | 162 |
|